Morphologic changes in explanted lungs after prostacyclin therapy for pulmonary hypertension
Prostacyclin (PGI2) causes vasodilation and inhibition of platelet aggregation in vivo. PGI2 is also postulated to affect pulmonary vascular remodeling, at least partly through anti-proliferative effect via PGI2 receptor (PGIR). However, the mechanism(s) of action by which (PGI2) exerts its therapeu...
Saved in:
Published in | European journal of medical research Vol. 11; no. 5; p. 203 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
05.05.2006
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Prostacyclin (PGI2) causes vasodilation and inhibition of platelet aggregation in vivo. PGI2 is also postulated to affect pulmonary vascular remodeling, at least partly through anti-proliferative effect via PGI2 receptor (PGIR). However, the mechanism(s) of action by which (PGI2) exerts its therapeutic effect is still not clear despite clear clinical benefit seen in severe pulmonary hypertension (PH) patients. We performed a histopathologic and morphometric study on the explanted lung tissues from PGI2-treated patients prior to lung transplantation (n = 9), in an attempt to elucidate morphologic changes associated with PGI2 treatment. Explanted lungs from PH patients without PGI2 treatment were examined as the control (n = 11). We also studied the possible differences in PGIR expression between the treated and untreated groups by immunohistochemical method. Seven out of 9 treated patients showed moderate to severe bronchial and perivascular inflammation, as opposed to only 1 such case in the control group. Five out of 9 treated cases showed moderate to severe alveolar edema with or without evidence of old hemorrhage, in contrast to only 1 case showing moderate alveolar edema in control patients. Morphometry did not reveal any significant difference between the two groups either in the % thickness of intima, media, or adventitia or in the density of plexiform lesions. Immunostain also failed to demonstrate any notable difference in PGIR expression. In conclusion, PGI2-treated cases revealed more pronounced pulmonary alveolar edema and inflammation, but no morphological evidence of altered vascular remodeling or PGIR expression after PGI2 therapy. |
---|---|
AbstractList | Prostacyclin (PGI2) causes vasodilation and inhibition of platelet aggregation in vivo. PGI2 is also postulated to affect pulmonary vascular remodeling, at least partly through anti-proliferative effect via PGI2 receptor (PGIR). However, the mechanism(s) of action by which (PGI2) exerts its therapeutic effect is still not clear despite clear clinical benefit seen in severe pulmonary hypertension (PH) patients. We performed a histopathologic and morphometric study on the explanted lung tissues from PGI2-treated patients prior to lung transplantation (n = 9), in an attempt to elucidate morphologic changes associated with PGI2 treatment. Explanted lungs from PH patients without PGI2 treatment were examined as the control (n = 11). We also studied the possible differences in PGIR expression between the treated and untreated groups by immunohistochemical method. Seven out of 9 treated patients showed moderate to severe bronchial and perivascular inflammation, as opposed to only 1 such case in the control group. Five out of 9 treated cases showed moderate to severe alveolar edema with or without evidence of old hemorrhage, in contrast to only 1 case showing moderate alveolar edema in control patients. Morphometry did not reveal any significant difference between the two groups either in the % thickness of intima, media, or adventitia or in the density of plexiform lesions. Immunostain also failed to demonstrate any notable difference in PGIR expression. In conclusion, PGI2-treated cases revealed more pronounced pulmonary alveolar edema and inflammation, but no morphological evidence of altered vascular remodeling or PGIR expression after PGI2 therapy. |
Author | Cool, Carlyne D Voelkel, Norbert F Yi, Eunhee S Achcar, Rosane O D Saffer, Helene Yung, Gordon L |
Author_xml | – sequence: 1 givenname: Rosane O D surname: Achcar fullname: Achcar, Rosane O D organization: Department of Pathology, University of Colorado Health Sciences Center, Denver, USA – sequence: 2 givenname: Gordon L surname: Yung fullname: Yung, Gordon L – sequence: 3 givenname: Helene surname: Saffer fullname: Saffer, Helene – sequence: 4 givenname: Carlyne D surname: Cool fullname: Cool, Carlyne D – sequence: 5 givenname: Norbert F surname: Voelkel fullname: Voelkel, Norbert F – sequence: 6 givenname: Eunhee S surname: Yi fullname: Yi, Eunhee S |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16723294$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tqwzAURLVIadI0v1D0AwZbDztaltAXpHTT7grhSrp-FFsSkgz139fQdjazOMMwc0M2zjvckF2phCoYZ9WWHFL6KlfVrG6Uuibbqm5WosSOfL76GHo_-m4w1PTgOkx0cBS_wwguo6Xj7LpEoc0YaYg-ZTCLGddI7jFCWGjrVzCPk3cQF9ovAWNGlwbvbslVC2PCw5_vycfjw_vpuTi_Pb2c7s9FYKXKBQcpRG01A0QutQQlZYOcN6VS1oJtTKPB2qrWR8O5ZMyIo2FGadUiViDYntz99oZZT2gvIQ7TuuXyf5P9AKbnU0g |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 16723294 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL60913-01 |
GroupedDBID | --- 53G 5GY ADBBV AENEX AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL CGR CUY CVF ECM EIF F5P GROUPED_DOAJ M~E NPM P2P |
ID | FETCH-LOGICAL-p209t-3a5446db2aee35b5a9557e337099ddad7c7badd16b8c33522c48c2c9b9fee1a42 |
ISSN | 0949-2321 |
IngestDate | Sat Sep 28 07:42:13 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p209t-3a5446db2aee35b5a9557e337099ddad7c7badd16b8c33522c48c2c9b9fee1a42 |
PMID | 16723294 |
ParticipantIDs | pubmed_primary_16723294 |
PublicationCentury | 2000 |
PublicationDate | 2006-May-05 |
PublicationDateYYYYMMDD | 2006-05-05 |
PublicationDate_xml | – month: 05 year: 2006 text: 2006-May-05 day: 05 |
PublicationDecade | 2000 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | European journal of medical research |
PublicationTitleAlternate | Eur J Med Res |
PublicationYear | 2006 |
SSID | ssj0000626799 |
Score | 1.8498323 |
Snippet | Prostacyclin (PGI2) causes vasodilation and inhibition of platelet aggregation in vivo. PGI2 is also postulated to affect pulmonary vascular remodeling, at... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 203 |
SubjectTerms | Adult Antihypertensive Agents - therapeutic use Epoprostenol - therapeutic use Female Humans Hypertension, Pulmonary - drug therapy Inflammation Lung - cytology Lung - pathology Lung Transplantation Male Middle Aged Pulmonary Artery - metabolism Pulmonary Artery - pathology Pulmonary Edema Receptors, Epoprostenol - metabolism Retrospective Studies |
Title | Morphologic changes in explanted lungs after prostacyclin therapy for pulmonary hypertension |
URI | https://www.ncbi.nlm.nih.gov/pubmed/16723294 |
Volume | 11 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA5TQXwR73fJg28SWdqmaR5l3hCmD06YIIwmTVCYs-gG6q_35GKtY4r6EkpDQ8n39eSc03NBaM8kTRlnihIBxwFJRKpJJllEAGyujDZSuvyK9kV6dp2cd1m30TC1qKXRUB6ot4l5Jf9BFe4BrjZL9g_IVovCDbgGfGEEhGH8FcbtR9glL71CBq-LbtUvZd9uWLHfH9mmnL4PeGnzO3L1anMh933alQ_WLEd9eGMbPXcHRumTC2kPYE1y2Qf19SH84QnVgiqv8qGy0WQ-aPs5BxX28jOo-CZIllOweIF1ld_5KrddWqpTsOJaK_T_atkqzLDU0biPgpEmqzsbE0FAd6Nf5C6t8YvVhairejCsAVg-OARpymER3xT559mxGtofU1NoimdWGl4En44_r6OUC1-UMbymLSUbHhkzN5za0VlA88FewIce_EXU0IMlNNsOERHL6LbGARw4gO8HuOIAdhzAjgO4zgEcOICBA7jiAK5zYAVdnxx3WmckdMwgZdQUQxLnDMz7Qka51jGTLBeMcR3HHOyAosgLrriEA42mMlM22S5SSaYiJaQwWtM8iVbR9OBxoNcRjmRiFNieGWg4CawiiwI0e0MzI2TKKd1Aa35feqUvi9L72LHNb2e20NwnO7bRjIHvUO-AUjeUuw6Td6iqU_A |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Morphologic+changes+in+explanted+lungs+after+prostacyclin+therapy+for+pulmonary+hypertension&rft.jtitle=European+journal+of+medical+research&rft.au=Achcar%2C+Rosane+O+D&rft.au=Yung%2C+Gordon+L&rft.au=Saffer%2C+Helene&rft.au=Cool%2C+Carlyne+D&rft.date=2006-05-05&rft.issn=0949-2321&rft.volume=11&rft.issue=5&rft.spage=203&rft_id=info%3Apmid%2F16723294&rft_id=info%3Apmid%2F16723294&rft.externalDocID=16723294 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0949-2321&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0949-2321&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0949-2321&client=summon |